Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.62 EUR | +5.13% | +15.62% | -34.25% |
Apr. 09 | BASTIDE LE CONFORT MEDICAL : EPS upgrade (2023: 0.0%, 2024: +1.6%) | |
Apr. 09 | Bastide: new contract with the British NHS | CF |
Sales 2024 * | 530M 567M | Sales 2025 * | 564M 603M | Capitalization | 131M 140M |
---|---|---|---|---|---|
Net income 2024 * | 16M 17.11M | Net income 2025 * | 22M 23.52M | EV / Sales 2024 * | 0.88 x |
Net Debt 2024 * | 337M 360M | Net Debt 2025 * | 331M 354M | EV / Sales 2025 * | 0.82 x |
P/E ratio 2024 * |
7.72
x | P/E ratio 2025 * |
5.65
x | Employees | 3,635 |
Yield 2024 * |
2.67% | Yield 2025 * |
2.74% | Free-Float | 44.92% |
1 day | +5.13% | ||
1 week | +15.62% | ||
Current month | +24.96% | ||
1 month | +21.35% | ||
3 months | -18.80% | ||
6 months | -16.29% | ||
Current year | -34.25% |
Managers | Title | Age | Since |
---|---|---|---|
Vincent Bastide
CEO | Chief Executive Officer | 54 | 97-12-28 |
Corporate Officer/Principal | 50 | 15-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Vincent Bastide
CEO | Chief Executive Officer | 54 | 97-12-28 |
Vanessa Giraud
BRD | Director/Board Member | 50 | - |
Olivier Mares
BRD | Director/Board Member | 47 | 19-07-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 17.62 | +5.13% | 30,215 |
24-04-25 | 16.76 | +0.48% | 13,661 |
24-04-24 | 16.68 | +6.38% | 17,669 |
24-04-23 | 15.68 | -0.51% | 5,670 |
24-04-22 | 15.76 | +3.41% | 83,018 |
Real-time Euronext Paris, April 26, 2024 at 11:35 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-34.25% | 133M | |
-3.44% | 2.98B | |
0.00% | 1.78B | |
+1.82% | 1.48B | |
+49.28% | 610M | |
-3.09% | 495M | |
-35.42% | 364M | |
-13.04% | 135M | |
+1.92% | 68.98M |
- Stock Market
- Equities
- BLC Stock